Home/Pipeline/OptiLIFT

OptiLIFT

Dry Eye Disease Management (IPL + Periorbital Stimulation)

CommercialActive

Key Facts

Indication
Dry Eye Disease Management (IPL + Periorbital Stimulation)
Phase
Commercial
Status
Active
Company

About Lumenis

Lumenis is a well-established, revenue-generating private company and a pioneer in energy-based medical technologies for aesthetics and vision care. With over 60 years of collective industry leadership (through its legacy), it boasts a significant global footprint with devices installed in over 88 countries. The company's core strength lies in its diversified portfolio of commercial platforms—including the M22, UltraPulse, LightSheer, and OptiLIGHT—which serve a large and growing market for minimally invasive procedures. Lumenis maintains its position through continuous innovation, a strong clinical publication record, and a deep focus on practitioner support and education.

View full company profile